French life science firm Cytoo announced today that it, Cellectis Bioresearch, and the French Alternative Energies and Atomic Energy Commission (CEA) are partnering to develop cell-based assays for drug development and toxicology.
NEW YORK (GenomeWeb News) – Promega today announced that it has inked an alliance with Puracyp, under which the firms are combining their cell line and assay technologies in an offering to researchers.
As other regulatory agencies worldwide approve the assay, Allergan estimates that the use of animal-based testing for Botox products could be reduced by up to 95 percent or more during the next three years.
The deal calls for ATCC to produce and authenticate cell banks and production lots of engineered and stock cell lines for use as cellular reagents as Promega creates a line of new cell-based assay systems for biologics.
Seahorse Extracellular and Flux Analyzers provide a kinetic method of measuring mitochondrial respiration and glycolysis, the two major energy-producing pathways, in living cells in a microplate, the company said.